Skip to content
Bench Press
  • Home
  • About Us
  • Science Insights
Bench Press
Research news from Mass General Brigham
Facebook Twitter Linkedin Instagram
  • Home
  • About Us
  • Science Insights

Posts Tagged ‘treatment-resistant depression’

Ketamine Approval Offers New Hope for Treatment-Resistant Depression, But Questions Remain

By Brian Burns | March 26, 2019
Sad woman

While the FDA’s approval of the first ketamine-based drug for treatment-resistant depression is encouraging, there are still a lot of details to work out, says Cristina Cusin, MD.

Read More

Research Shows Ketamine Could Be an Answer for Treatment-Resistant Depression

By MGH Research Institute | October 25, 2018

A Mass General research team is working to identify the ideal dosages for treating depression with ketamine.

Read More
© 2026 Bench Press | Powered by Beaver Builder